Fulton Financial Corp. 8-K Summary: Merger with Blue Foundry Bancorp
Business Context and Reporting Period
This Current Report on Form 8-K, dated November 25, 2025, reports on events occurring on November 24, 2025. Fulton Financial Corporation ("Fulton") entered into a definitive Agreement and Plan of Merger with Blue Foundry Bancorp ("Blue Foundry"). Under the agreement, Blue Foundry will merge with and into Fulton, with Fulton surviving. Blue Foundry Bank will subsequently merge into Fulton Bank, N.A.
Key Financial Metrics and Transaction Terms
The filing details the structure of the merger consideration rather than Fulton's standalone financial performance for the period.
- Exchange Ratio: Each share of Blue Foundry Common Stock will be converted into the right to receive 0.650 shares of Fulton Common Stock.
- Fractional Shares: Cash will be paid in lieu of fractional shares.
- Equity Awards: Outstanding Blue Foundry options will fully vest and be converted into cash payments based on the excess of the cashout price over the exercise price. Restricted stock awards will fully vest and convert into the Merger Consideration.
- Termination Fee: A termination fee of $9,694,662 is payable by Blue Foundry if the agreement is terminated under certain specified circumstances.
Note: The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for Fulton or Blue Foundry for the reporting period.
Material Changes and Conditions
The primary material change is the execution of the Merger Agreement. Completion of the transaction is subject to several conditions, including:
- Approval by Blue Foundry stockholders.
- Required regulatory approvals from the Federal Reserve Board, the Office of the Comptroller of the Currency, and the New Jersey Department of Banking and Insurance.
- Effectiveness of the registration statement on Form S-4.
- Non-objection by Nasdaq to the listing of Fulton shares to be issued.
- Absence of laws or injunctions prohibiting the merger.
The agreement includes a "Materially Burdensome Regulatory Condition" clause, allowing parties to avoid actions that would materially impair the benefits of the transaction.
Outlook, Risks, and Management Commentary
Management anticipates strategic and financial benefits, including expected accretion to earnings per share, though specific pro forma numbers are not included in this filing. The document contains extensive forward-looking statements regarding the integration and future performance.
Key Risks Identified:
- Failure to realize revenue or expense synergies and cost savings.
- Delays or failure to obtain necessary regulatory or stockholder approvals.
- Dilution to Fulton shareholders from the issuance of new common stock.
- Diversion of management attention from ongoing operations.
- Integration challenges, including system conversions and data migration.
- Macroeconomic factors, including interest rate changes and potential recession.
Investor Verification Checklist
- Verify the final exchange ratio and any adjustments in the upcoming Form S-4 proxy statement/prospectus.
- Confirm the status of regulatory approvals from the Federal Reserve, OCC, and New Jersey banking authorities.
- Review the detailed pro forma financial information and accretion/dilution analysis in the Form S-4.
- Monitor the timeline for the Blue Foundry stockholder vote and the expected closing date.
- Assess the specific terms of the termination fee and the conditions under which it is triggered.